T.-U. Hausamen

532 total citations
30 papers, 306 citations indexed

About

T.-U. Hausamen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, T.-U. Hausamen has authored 30 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in T.-U. Hausamen's work include Helicobacter pylori-related gastroenterology studies (5 papers), Gastroesophageal reflux and treatments (3 papers) and Gastrointestinal motility and disorders (2 papers). T.-U. Hausamen is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (5 papers), Gastroesophageal reflux and treatments (3 papers) and Gastrointestinal motility and disorders (2 papers). T.-U. Hausamen collaborates with scholars based in Germany and United States. T.-U. Hausamen's co-authors include Tina Loeffler, F. Große-Brockhoff, U Peters, W.-P. Fritsch, Wirnt Rick, G. F. Bottazzo, J. Chayen, Lucille Bitensky, Jonathan Fisher and Jerry D. Gardner and has published in prestigious journals such as Gastroenterology, Annals of Oncology and Advances in experimental medicine and biology.

In The Last Decade

T.-U. Hausamen

25 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.-U. Hausamen Germany 10 112 85 83 73 34 30 306
R Laumonier France 8 63 0.6× 77 0.9× 66 0.8× 61 0.8× 11 0.3× 60 330
Ross Js United States 11 69 0.6× 138 1.6× 92 1.1× 81 1.1× 32 0.9× 20 397
G Delpré Israel 11 64 0.6× 150 1.8× 101 1.2× 61 0.8× 33 1.0× 24 377
P H Cugnenc France 11 112 1.0× 268 3.2× 98 1.2× 131 1.8× 19 0.6× 30 503
Di Mario F Italy 11 71 0.6× 217 2.6× 59 0.7× 80 1.1× 112 3.3× 38 374
A Hartmann Brazil 12 70 0.6× 145 1.7× 118 1.4× 90 1.2× 27 0.8× 42 374
Tomoko Hagiwara Japan 12 47 0.4× 116 1.4× 109 1.3× 79 1.1× 26 0.8× 27 378
Ming-Shyan Huang Taiwan 9 113 1.0× 64 0.8× 164 2.0× 84 1.2× 7 0.2× 19 428
Kumi Ishida Japan 11 62 0.6× 134 1.6× 50 0.6× 49 0.7× 41 1.2× 31 343

Countries citing papers authored by T.-U. Hausamen

Since Specialization
Citations

This map shows the geographic impact of T.-U. Hausamen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.-U. Hausamen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.-U. Hausamen more than expected).

Fields of papers citing papers by T.-U. Hausamen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.-U. Hausamen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.-U. Hausamen. The network helps show where T.-U. Hausamen may publish in the future.

Co-authorship network of co-authors of T.-U. Hausamen

This figure shows the co-authorship network connecting the top 25 collaborators of T.-U. Hausamen. A scholar is included among the top collaborators of T.-U. Hausamen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.-U. Hausamen. T.-U. Hausamen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Löhlein, D., et al.. (2008). Akute intrahepatische Blutung bei einem männlichen Patienten mit fokalnodulärer Hyperplasie. DMW - Deutsche Medizinische Wochenschrift. 121(28/29). 902–905. 1 indexed citations
2.
Hausamen, T.-U., et al.. (2008). Myelosuppression mit makrozytärer Anämie und Leukopenie unter Behandlung mit Azathioprin bei Myasthenia gravis. DMW - Deutsche Medizinische Wochenschrift. 107(42). 1592–1594.
3.
Loeffler, Tina, et al.. (1999). Substantial activity of budesonide in patients with irinotecan (CPT-11) and 5-fluorouracil induced diarrhea and failure of loperamide treatment. Annals of Oncology. 10(10). 1251–1253. 62 indexed citations
4.
Loeffler, Tina & T.-U. Hausamen. (1996). High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.. PubMed. 6(3). 137–40. 1 indexed citations
5.
Hausamen, T.-U., et al.. (1996). Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: results of a phase I/II trial.. PubMed. 23(6 Suppl 16). 32–4. 43 indexed citations
6.
Löffler, Thorsten, et al.. (1993). [Results of preoperative radio-chemotherapy in locally advanced squamous epithelial cancer of the esophagus].. PubMed. 64(9). 701–7; discussion 707.
7.
Löffler, Thomas, F.W. Korsten, M. Planker, et al.. (1992). Fluorouracil als Monotherapie oder in Kombination mit Folinsäure in der Behandlung des metastasierten kolorektalen Karzinoms. DMW - Deutsche Medizinische Wochenschrift. 117(26). 1007–1013. 15 indexed citations
8.
Loeffler, Tina, et al.. (1991). Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study. Journal of Cancer Research and Clinical Oncology. 117(S4). S125–S128. 13 indexed citations
9.
Loeffler, Tina, et al.. (1988). Chemotherapy of Advanced and Relapsed Squamous Cell Cancer of the Head and Neck with Split-Dose Cisplatinum (DDP), 5-Fluorouracil (Fura) and Leucovorin (CF). Advances in experimental medicine and biology. 244. 267–273. 7 indexed citations
10.
Hausamen, T.-U., et al.. (1977). Behandlung peptischer Ulzera beim Zollinger-Ellison-Syndrom mit Histamin-H2-Rezeptor-Antagonisten*1. DMW - Deutsche Medizinische Wochenschrift. 102(47). 1709–1712. 4 indexed citations
11.
Schacht, U., W.-P. Fritsch, P. Rumpf, Griet Jacobs, & T.-U. Hausamen. (1977). Stimulation der H+-Sekretion und des Serum-Gastrins durch intraoperativen elektrischen Vagusreiz vor und nach proximaler selektiver Vagotomie. DMW - Deutsche Medizinische Wochenschrift. 102(24). 894–896. 1 indexed citations
12.
Peters, U, et al.. (1977). Pharmakokinetik von Digitoxin bei chronischer Niereninsuffizienz*. DMW - Deutsche Medizinische Wochenschrift. 102(4). 109–115. 9 indexed citations
13.
Fritsch, W.-P., T.-U. Hausamen, & Wirnt Rick. (1976). Gastric and Extragastric Gastrin Release in Normal Subjects, in Duodenal Ulcer Patients, and in Patients With Partial Gastrectomy (Billroth I). Gastroenterology. 71(4). 552–557. 36 indexed citations
14.
Fritsch, W.-P., et al.. (1976). Serum-Gastrinspiegel und Magensäuresekretion im Säuglingsalter*. DMW - Deutsche Medizinische Wochenschrift. 101(49). 1800–1805. 1 indexed citations
15.
Große-Brockhoff, F. & T.-U. Hausamen. (1975). 200 Jahre Herztherapie mit Digitalis. DMW - Deutsche Medizinische Wochenschrift. 100(39). 1980–1991. 1 indexed citations
16.
Peters, U, T.-U. Hausamen, & F. Große-Brockhoff. (1974). Einfluß von Tuberkulostatika auf die Pharmakokinetik des Digitoxins. DMW - Deutsche Medizinische Wochenschrift. 99(47). 2381–2386. 33 indexed citations
17.
Risler, T., B. Grabensee, T.-U. Hausamen, E. Schröder, & F. Große-Brockhoff. (1974). [Clearance of digoxin in persons with healthy kidneys and in patients with reduced renal function].. PubMed. 40. 306–8. 1 indexed citations
18.
Hausamen, T.-U., et al.. (1969). Biological Effects of Gastrointestinal Antibodies. Gastroenterology. 56(6). 1071–1077. 3 indexed citations
19.
Breddin, K, et al.. (1969). [On the systemic effect of orally administered bromelin].. PubMed. 19(6). 939–44. 2 indexed citations
20.
Hausamen, T.-U. & Wirnt Rick. (1967). Zur exokrinen Pankreasfunktion nach Cholecystektomie. Digestion. 107(3). 179–184. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026